Determining Sample Size for Post-Marketing Surveillance of Rare Adverse Events251.Wang, JianminSherrill, BethIrish, WilliamAuthor informationRTI Health Solution, Research Triangle Park, United States.Pharmacoepidemiology and Drug Safety 16:p S119-S120, July 2007.Copyright © 2007 John Wiley & Sons, Inc.